2020

1. Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry

   Actas Dermo-Sifiliograficas, Vol. 111, Núm. 9, pp. 752-760

2. Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

   Journal of the American Academy of Dermatology, Vol. 83, Núm. 1, pp. 139-150

3. The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study

   Journal of the American Academy of Dermatology, Vol. 82, Núm. 3, pp. 738-741